相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up study
Susan Friend et al.
BMC NEUROLOGY (2016)
New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies
T. Sehr et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Transfer of Natalizumab into Breast Milk in a Mother with Multiple Sclerosis
Teresa E. Baker et al.
JOURNAL OF HUMAN LACTATION (2015)
Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study
Neda Ebrahimi et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Normal outcome of pregnancy with ongoing treatment with natalizumab
J. Fagius et al.
ACTA NEUROLOGICA SCANDINAVICA (2014)
Therapeutic monoclonal antibodies in human breast milk: a case study
Elle Ross et al.
MELANOMA RESEARCH (2014)
Natalizumab Use During the Third trimester of Pregnancy
Aiden Haghikia et al.
JAMA NEUROLOGY (2014)
Natalizumab treatment during pregnancy - effects on the neonatal immune system
H. Schneider et al.
ACTA NEUROLOGICA SCANDINAVICA (2013)
Natalizumab Bench to Bedside and Beyond
Richard Rudick et al.
JAMA NEUROLOGY (2013)
Accidental natalizumab administration to the third trimester of pregnancy in an adolescent patient with multiple sclerosis
A. Bayas et al.
ACTA NEUROLOGICA SCANDINAVICA (2011)
Transplacental Transfer of Immunosuppressants and Biologics Used for the Treatment of Inflammatory Bowel Disease
Maria Chaparro et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment
Kerstin Hellwig et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Perspectives on Immunoglobulins in Colostrum and Milk
Walter L. Hurley et al.
NUTRIENTS (2011)
Receptor-mediated uptake and transport of macromolecules in the human placenta
Henning Schneider et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2010)
Embryo/Fetal Development in Cynomolgus Monkeys Exposed to Natalizumab, an α4 Integrin Inhibitor
Nancy G. Wehner et al.
BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY (2009)
Postnatal Development in Cynomolgus Monkeys Following Prenatal Exposure to Natalizumab, an α4 Integrin Inhibitor
Nancy G. Wehner et al.
BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY (2009)
Effects of Natalizumab, an α4 Integrin Inhibitor, on the Development of Hartley Guinea Pigs
Nancy G. Wehner et al.
BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY (2009)
Over-expression of the bovine FcRn in the mammary gland results in increased IgG levels in both milk and serum of transgenic mice
Wei Lu et al.
IMMUNOLOGY (2007)
Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis
F Forger et al.
LUPUS (2004)
Mucosal immunity: integration between mother and the breast-fed infant
P Brandtzaeg
VACCINE (2003)
分享论文
